First serological evidence of MERS-CoV in dromedary camels from Algeria.
In: Comparative immunology, microbiology and infectious diseases, Jg. 103 (2023-12-01), S. 102078
Online
academicJournal
Zugriff:
Middle East Respiratory Syndrome (MERS) is a zoonotic disease. Dromedary camel is responsible of its transmission to humans. Accordingly, several human cases have been reported worldwide with a high mortality rate. In Algeria, no data reported on MERS prevalence in camels. This is a first seroprevalence study MERS-CoV in Algerian dromedaries. A total of 87 camel blood samples from EL -MENIAA and Ghardaia, were analyzed by anti-MERS-CoV IgG ELISA camel. The seroprevalence was 64 % and it significantly increases with age. Larger serological and molecular screening is needed to precisely determine the rate of MERS active circulation among Algerian dromedary population.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier Ltd. All rights reserved.)
Titel: |
First serological evidence of MERS-CoV in dromedary camels from Algeria.
|
---|---|
Autor/in / Beteiligte Person: | Haroun, MA ; Khames, M ; Fettata, S ; Khames, Y ; El-Hassani, M ; Zerouak, N ; Benachour, K ; Oumouna, M |
Link: | |
Zeitschrift: | Comparative immunology, microbiology and infectious diseases, Jg. 103 (2023-12-01), S. 102078 |
Veröffentlichung: | Exeter : Elsevier Science Ltd ; <i>Original Publication</i>: Oxford, Elmsford, N. Y., Pergamon Press., 2023 |
Medientyp: | academicJournal |
ISSN: | 1878-1667 (electronic) |
DOI: | 10.1016/j.cimid.2023.102078 |
Schlagwort: |
|
Sonstiges: |
|